182 related articles for article (PubMed ID: 29554108)
1. The economic burden of rotavirus infection in South Korea from 2009 to 2012.
Lee KS; Lee YR; Park SY; Oh IH
PLoS One; 2018; 13(3):e0194120. PubMed ID: 29554108
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
[TBL] [Abstract][Full Text] [Related]
3. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.
Kang HY; Kim KH; Kim JH; Kim HM; Kim J; Kim MS; El Khoury AC; Kim DS
Asia Pac J Public Health; 2013 Mar; 25(2):145-58. PubMed ID: 22234827
[TBL] [Abstract][Full Text] [Related]
5. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
[TBL] [Abstract][Full Text] [Related]
6. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
7. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of rotavirus vaccination in Turkey.
Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
[TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
[TBL] [Abstract][Full Text] [Related]
10. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
11. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
13. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.
Valencia-Mendoza A; Bertozzi SM; Gutierrez JP; Itzler R
BMC Infect Dis; 2008 Jul; 8():103. PubMed ID: 18664280
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
Tucker AW; Haddix AC; Bresee JS; Holman RC; Parashar UD; Glass RI
JAMA; 1998 May; 279(17):1371-6. PubMed ID: 9582045
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
[TBL] [Abstract][Full Text] [Related]
18. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.
Lorgelly PK; Joshi D; Iturriza Gómara M; Gray J; Mugford M
Epidemiol Infect; 2008 Jan; 136(1):44-55. PubMed ID: 17335631
[TBL] [Abstract][Full Text] [Related]
19. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of studies on rotavirus disease cost-of-illness and productivity loss in Latin America and the Caribbean.
Takemoto ML; Bahia L; Toscano CM; Araujo DV
Vaccine; 2013 Jul; 31 Suppl 3():C45-57. PubMed ID: 23777691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]